Guy Levy serves as Executive at BioAtla, Inc., where they oversee executive responsibilities. Since joining the company, Guy Levy has executed 9 insider transactions totaling $62.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 30, 2021 involved receiving (via award) 267,900 shares valued at $7.5M.
Guy Levy currently holds 1,115,817 shares of BioAtla, Inc. (BCAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Guy Levy has been a net seller of BCAB stock. They have purchased $25.0M and sold $37.3M worth of shares.
Guy Levy's most recent insider trade was on Sep 30, 2021, when they sold 267,900 shares at $28.00 per share.
Get notified when new Form 4 filings are submitted
| $39.65 |
| Discretionary |
| Aug 24, 2021 | BCAB | $2.1M | Sale | 53,195 | $39.65 | Discretionary |
| Aug 24, 2021 | BCAB | $11.3M | Sale | 285,874 | $39.65 | Discretionary |
| Jun 17, 2021 | BCAB | $13.2M | Sale | 337,220 | $39.16 | Discretionary |
| Jun 17, 2021 | BCAB | $2.5M | Sale | 62,780 | $39.16 | Discretionary |
| Dec 18, 2020 | BCAB | $6.0M | Purchase | 333,333 | $18.00 | Discretionary |
| Dec 18, 2020 | BCAB | $19.0M | Purchase | 1,055,557 | $18.00 | Discretionary |
| Dec 18, 2020 | BCAB | $0 | Conversion | 1,790,472 | $N/A | Discretionary |